Speaking of Oralyn and insulin, did anyone read th
Post# of 36537
https://www.nytimes.com/2019/01/18/opinion/co...e=Homepage
Infuriating how the 3 companies who sell insulin play games to keep it under patent and jack up the prices. Patients and doctors suffer.
How about Generex getting involved - find a financier for the type 2 trial, get Oralyn approved, and then manufacture the insulin ourselves and sell a complete product. Patient and doctors would flock to it. What an unmet need.